These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 7511188)

  • 1. Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma.
    Tuszynski GP; Nicosia RF
    Lab Invest; 1994 Feb; 70(2):228-33. PubMed ID: 7511188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast.
    Clezardin P; Frappart L; Clerget M; Pechoux C; Delmas PD
    Cancer Res; 1993 Mar; 53(6):1421-30. PubMed ID: 7680285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. An immunohistochemical study.
    Wong SY; Purdie AT; Han P
    Am J Pathol; 1992 Jun; 140(6):1473-82. PubMed ID: 1351369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathology and clinical assessment correlate with the cysteine-serine-valine-threonine-cysteine-glycine (CSVTCG) receptor of thrombospondin-1 in breast tumors.
    Roth JJ; Reiver DM; Granick MS; Rothman VL; Nicosia RF; Tuszynski GP
    Histol Histopathol; 1997 Oct; 12(4):1013-8. PubMed ID: 9302563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
    Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human carcinoma cells bind thrombospondin through a Mr 80,000/105,000 receptor.
    Yabkowitz R; Dixit VM
    Cancer Res; 1991 Jul; 51(14):3648-56. PubMed ID: 1712244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
    Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
    J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of thrombospondin on invasion of fibrin gels by human A549 lung carcinoma.
    Hosokawa T; Muraishi A; Rothman VL; Papale M; Tuszynski GP
    Oncol Res; 1993; 5(4-5):183-9. PubMed ID: 8305744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of thrombospondin in hepatocellular carcinoma.
    Hayashi K; Kurohiji T; Shirouzu K
    Hepatology; 1997 Mar; 25(3):569-74. PubMed ID: 9049200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of keratins 13 and 16 in normal epithelium, benign lesions, and ductal carcinomas of the human breast determined by the monoclonal antibody Ks8.12.
    Pellegrino MB; Asch BB; Connolly JL; Asch HL
    Cancer Res; 1988 Oct; 48(20):5831-6. PubMed ID: 2458830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The localization of thrombospondin-1 (TSP-1), cysteine-serine-valine-threonine-cysteine-glycine (CSVTCG) TSP receptor, and matrix metalloproteinase-9 (MMP-9) in colorectal cancer.
    Wakiyama T; Shinohara T; Shirakusa T; John AS; Tuszynski GP
    Histol Histopathol; 2001 Apr; 16(2):345-51. PubMed ID: 11332689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteine proteinase inhibitor cystatin A in breast cancer.
    Kuopio T; Kankaanranta A; Jalava P; Kronqvist P; Kotkansalo T; Weber E; Collan Y
    Cancer Res; 1998 Feb; 58(3):432-6. PubMed ID: 9458085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of platelet-derived growth factor beta receptor expression in the periepithelial stroma of human breast carcinoma.
    Bhardwaj B; Klassen J; Cossette N; Sterns E; Tuck A; Deeley R; Sengupta S; Elliott B
    Clin Cancer Res; 1996 Apr; 2(4):773-82. PubMed ID: 9816230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of estrogen, progesterone, and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry.
    van Agthoven T; Timmermans M; Foekens JA; Dorssers LC; Henzen-Logmans SC
    Am J Pathol; 1994 Jun; 144(6):1238-46. PubMed ID: 7515559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of thrombospondin-1 in tumor progression and angiogenesis.
    Tuszynski GP; Nicosia RF
    Bioessays; 1996 Jan; 18(1):71-6. PubMed ID: 8593167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical localization of integrins in the normal, hyperplastic, and neoplastic breast. Correlations with their functions as receptors and cell adhesion molecules.
    Koukoulis GK; Virtanen I; Korhonen M; Laitinen L; Quaranta V; Gould VE
    Am J Pathol; 1991 Oct; 139(4):787-99. PubMed ID: 1928301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).
    Niehans GA; Cherwitz DL; Staley NA; Knapp DJ; Dalmasso AP
    Am J Pathol; 1996 Jul; 149(1):129-42. PubMed ID: 8686736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunolocalization and gene expression of oxytocin receptors in carcinomas and non-neoplastic tissues of the breast.
    Bussolati G; Cassoni P; Ghisolfi G; Negro F; Sapino A
    Am J Pathol; 1996 Jun; 148(6):1895-903. PubMed ID: 8669475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sialoglycoprotein (LEA.135) associated with favourable prognosis of patients with lymph node-negative primary breast carcinoma.
    Imam SA; Chaiwun B; Wang MJ; Morris MM; Groshen SG; Neville AM; Torloni H; Cote RJ; Taylor CR
    Anticancer Res; 1996; 16(5B):3043-8. PubMed ID: 8920764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.